Abstract

Follicular lymphoma is a usually Indolent lymphoma that responds well to chemotherapy. While multiple treatments show a good response rate, most patients relapse. Emerging therapies, such as antibody therapy and stem cell transplantation, are increasingly being used to try to lengthen response time. This article will review the available treatments for follicular lymphoma and discuss the studies supporting newer strategies of treatment.

Original languageEnglish (US)
Pages (from-to)66-71
Number of pages6
JournalSeminars in Oncology
Volume31
Issue number2 SUPPL. 4
DOIs
StatePublished - Apr 2004

Fingerprint

Follicular Lymphoma
Therapeutics
Stem Cell Transplantation
Reaction Time
Lymphoma
Recurrence
Drug Therapy
Antibodies

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Advances in Follicular-Lymphoma. / Archuleta, Travis D.; Armitage, James Olen.

In: Seminars in Oncology, Vol. 31, No. 2 SUPPL. 4, 04.2004, p. 66-71.

Research output: Contribution to journalArticle

Archuleta, Travis D. ; Armitage, James Olen. / Advances in Follicular-Lymphoma. In: Seminars in Oncology. 2004 ; Vol. 31, No. 2 SUPPL. 4. pp. 66-71.
@article{2e62f4388a714e13bfb9f9462e5aa8d4,
title = "Advances in Follicular-Lymphoma",
abstract = "Follicular lymphoma is a usually Indolent lymphoma that responds well to chemotherapy. While multiple treatments show a good response rate, most patients relapse. Emerging therapies, such as antibody therapy and stem cell transplantation, are increasingly being used to try to lengthen response time. This article will review the available treatments for follicular lymphoma and discuss the studies supporting newer strategies of treatment.",
author = "Archuleta, {Travis D.} and Armitage, {James Olen}",
year = "2004",
month = "4",
doi = "10.1053/j.seminoncol.2004.02.007",
language = "English (US)",
volume = "31",
pages = "66--71",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "2 SUPPL. 4",

}

TY - JOUR

T1 - Advances in Follicular-Lymphoma

AU - Archuleta, Travis D.

AU - Armitage, James Olen

PY - 2004/4

Y1 - 2004/4

N2 - Follicular lymphoma is a usually Indolent lymphoma that responds well to chemotherapy. While multiple treatments show a good response rate, most patients relapse. Emerging therapies, such as antibody therapy and stem cell transplantation, are increasingly being used to try to lengthen response time. This article will review the available treatments for follicular lymphoma and discuss the studies supporting newer strategies of treatment.

AB - Follicular lymphoma is a usually Indolent lymphoma that responds well to chemotherapy. While multiple treatments show a good response rate, most patients relapse. Emerging therapies, such as antibody therapy and stem cell transplantation, are increasingly being used to try to lengthen response time. This article will review the available treatments for follicular lymphoma and discuss the studies supporting newer strategies of treatment.

UR - http://www.scopus.com/inward/record.url?scp=2342660723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342660723&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2004.02.007

DO - 10.1053/j.seminoncol.2004.02.007

M3 - Article

C2 - 15124137

AN - SCOPUS:2342660723

VL - 31

SP - 66

EP - 71

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 2 SUPPL. 4

ER -